Related Experiment Video
Updated: Mar 28, 2026

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Norepinephrine Dosing in Obese and Nonobese Patients With Septic Shock
John J Radosevich1, Asad E Patanwala2, Brian L Erstad1
1John J. Radosevich is a clinical pharmacist, critical care, Pharmacy Department, St Joseph's Hospital and Medical Center, Phoenix, Arizona. Asad E. Patanwala is an associate professor and Brian L. Erstad is a professor and department head, Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, Arizona.
Background:
Whether or not norepinephrine infusions for support of hemodynamic status in patients with septic shock should be weight based is unknown. This situation is particularly pertinent in patients who are extremely overweight or obese.
Objective:
To compare dosing requirements and effect of norepinephrine on blood pressure in obese and nonobese patients with septic shock.
Methods:
In a retrospective cohort study, data on adult patients with septic shock who received norepinephrine infusion for support of hemodynamic status in a tertiary care, academic medical center were analyzed. Patients were categorized as obese (body mass index ≥ 30) or nonobese (body mass index < 30). The primary outcome was dosing requirements of norepinephrine at 60 minutes after the start of the infusion. The secondary outcome was the log-transformed ratio of mean arterial pressure to norepinephrine.
Results:
The final cohort consisted of 100 obese and 100 nonobese patients. Mean norepinephrine infusion rate at 60 minutes was 0.09 (SD, 0.08) μg/kg per minute in the obese group and 0.13 (SD, 0.14) μg/kg per minute in the nonobese group (P = .006). The non-weight-based dose at 60 minutes was 9 μg/min in obese patients and 8 μg/min in nonobese patients (P = .72). The log transformed mean arterial pressure to norepinephrine ratio at 60 minutes was 2.5 (SD, 0.9) in obese patients and 2.5 (SD, 0.8) in nonobese patients (P = .54) CONCLUSIONS: Compared with nonobese patients, obese patients with septic shock require lower weight-based doses of norepinephrine and similar total norepinephrine doses.
Related Concept Videos
Drug Dosing: Obese Patients
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
